发明名称 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
摘要 This invention concerns a bicyclic compound of Formula (I), wherein: G is N, CH or C(CN); ring X is a 5- or 6-membered fused heteroaryl ring which contains 1, 2, or 3 heteroatoms selected from oxygen, sulphur and nitrogen; m is 0-2; R<1 >is a group such as hydroxy, halo, trifluoromethyl, cyano, mercapto, nitro, amino, carboxy and carbamoyl; each of R<2 >and R<3 >is hydrogen, halo, C1-6alkyl, C2-6alkenyl or C2-6 alkynyl; R<4 >is a group such as hydrogen, hydroxy, C1-6alkyl, C1-6alkoxy, amino and N-C1-6alkylamino; R<5 >is a group such as hydrogen, halo, trifluoromethyl, cyano, nitro, amino and hydroxy, and q is 0-4; or a pharmaceutically acceptable salt or an in vivo cleavable ester thereof; processes for its preparation, a pharmaceutical composition containing it and its use in the treatment of diseases or medical conditions mediated by cytokines.
申请公布号 US6784174(B1) 申请公布日期 2004.08.31
申请号 US20010937018 申请日期 2001.09.20
申请人 ASTRAZENECA AB 发明人 CUMMING JOHN G
分类号 C07D473/34;A61K31/519;A61K31/52;A61P1/02;A61P1/04;A61P1/16;A61P7/02;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/06;A61P19/00;A61P19/02;A61P19/06;A61P19/10;A61P21/00;A61P25/28;A61P29/00;A61P31/04;A61P31/10;A61P31/12;A61P31/18;A61P35/00;A61P35/04;A61P37/08;A61P43/00;C07D471/04;C07D475/06;C07D495/04;C07D513/04;(IPC1-7):C07D495/04;A61K31/33 主分类号 C07D473/34
代理机构 代理人
主权项
地址